Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt No Debt
PTIX's Cash-to-Debt is ranked higher than
98% of the 864 Companies
in the Global Biotechnology industry.

( Industry Median: 53.59 vs. PTIX: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
PTIX' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 20.69 Max: No Debt
Current: No Debt
Piotroski F-Score: 3
Altman Z-Score: 13.06
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
ROE % -121.44
PTIX's ROE % is ranked lower than
82% of the 773 Companies
in the Global Biotechnology industry.

( Industry Median: -39.29 vs. PTIX: -121.44 )
Ranked among companies with meaningful ROE % only.
PTIX' s ROE % Range Over the Past 10 Years
Min: -326.23  Med: -50.57 Max: -5.51
Current: -121.44
-326.23
-5.51
ROA % -83.68
PTIX's ROA % is ranked lower than
80% of the 870 Companies
in the Global Biotechnology industry.

( Industry Median: -33.51 vs. PTIX: -83.68 )
Ranked among companies with meaningful ROA % only.
PTIX' s ROA % Range Over the Past 10 Years
Min: -3120  Med: -41.2 Max: -2.7
Current: -83.68
-3120
-2.7
ROC (Joel Greenblatt) % -155250.00
PTIX's ROC (Joel Greenblatt) % is ranked lower than
97% of the 827 Companies
in the Global Biotechnology industry.

( Industry Median: -476.30 vs. PTIX: -155250.00 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
PTIX' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -155250  Med: -433.16 Max: -6.15
Current: -155250
-155250
-6.15
3-Year Revenue Growth Rate -100.00
PTIX's 3-Year Revenue Growth Rate is ranked lower than
93% of the 485 Companies
in the Global Biotechnology industry.

( Industry Median: 4.80 vs. PTIX: -100.00 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
PTIX' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: -100 Max: 11.5
Current: -100
0
11.5
3-Year EBITDA Growth Rate -83.80
PTIX's 3-Year EBITDA Growth Rate is ranked lower than
99% of the 515 Companies
in the Global Biotechnology industry.

( Industry Median: 0.20 vs. PTIX: -83.80 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
PTIX' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 1.6 Max: 955.8
Current: -83.8
0
955.8
GuruFocus has detected 5 Warning Signs with Protagenic Therapeutics Inc $PTIX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» PTIX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with PTIX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Biotechnology » Biotechnology    NAICS: 325412    SIC: 2834
Compare:NAS:BDSI, NAS:CASC, AMEX:BTX, NAS:BSTC, NAS:ANIP, NAS:BCRX, NAS:BMRN » details
Atrinsic Inc is engaged in the process of developing an online affiliated marketing network targeting the Mommy Market.

Atrinsic Inc was incorporated in 1994 under the laws of the state of Delaware. The Company is a marketer of direct-to-consumer subscription products and an Internet search-marketing agency. The Company sells entertainment and lifestyle subscription products directly to consumers, which it market through the Internet. It also sells Internet marketing services to its corporate and advertising clients. The Company has developed its marketing media network, consisting of web sites, proprietary content and licensed media, to attract consumers, corporate partners and advertisers. The Company thinks its marketing media network and proprietary technology allows it to cost-effectively acquire consumers for its products and for its corporate partners and advertisers. Its usiness is focused on two key areas: (i) Direct-to consumer subscriptions, built around the Kazaa brand. Search and affiliate marketing, built around the Atrinsic Interactive brand. Its direct-to-consumer subscription business is built around a recurring-revenue business model. The Company is focused on digital music in the rapidly growing mobile space, and its offering, Kazaa, is a recognizable brand in this market. It also provides alternative billing capabilities, allowing its subscribers to utilize payment methods other than just credit cards, to purchase its services. Its core strategic focus for Kazaa and its direct-to-consumer subscription business is to build and sustain a profitable subscriber base and a growing and engaged audience and to deliver entertainment content to its customers anywhere, anytime and on any device, in a manner its customers choose. Atrinsic Interactive, its affiliate network and search marketing agency, is a top ten search agency according to Advertising Age (2010) and a top-tier affiliate network. The Company offer advertisers an integrated service offering across paid search, or search engine marketing ('SEM'), search engine optimization ('SEO'), display advertising, affiliate marketing, as well as offering business intelligence and brand protection services to its clients. It works with all types and sizes of advertisers on a performance basis to assist them in acquiring customers at an attractive return on investment. Its core strategic focus for Atrinsic Interactive is to build an independent search marketing agency and a top-five affiliate network. The Company faces competition from a pool of advertising, media, Internet companies and wireless and traditional telephone carriers. The Company is subject to a variety of Federal, State and Local laws and regulations designed to protect consumers that govern certain of its marketing and information collection practices.

Ratios

vs
industry
vs
history
PB Ratio 6.21
PTIX's PB Ratio is ranked lower than
71% of the 1091 Companies
in the Global Biotechnology industry.

( Industry Median: 3.76 vs. PTIX: 6.21 )
Ranked among companies with meaningful PB Ratio only.
PTIX' s PB Ratio Range Over the Past 10 Years
Min: 0.79  Med: 3.34 Max: 29.59
Current: 6.21
0.79
29.59
Current Ratio 5.53
PTIX's Current Ratio is ranked higher than
61% of the 838 Companies
in the Global Biotechnology industry.

( Industry Median: 4.03 vs. PTIX: 5.53 )
Ranked among companies with meaningful Current Ratio only.
PTIX' s Current Ratio Range Over the Past 10 Years
Min: 0.03  Med: 1.63 Max: 6.28
Current: 5.53
0.03
6.28
Quick Ratio 5.53
PTIX's Quick Ratio is ranked higher than
62% of the 838 Companies
in the Global Biotechnology industry.

( Industry Median: 3.74 vs. PTIX: 5.53 )
Ranked among companies with meaningful Quick Ratio only.
PTIX' s Quick Ratio Range Over the Past 10 Years
Min: 0.03  Med: 0.83 Max: 6.28
Current: 5.53
0.03
6.28

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -115.40
PTIX's 3-Year Average Share Buyback Ratio is ranked lower than
94% of the 563 Companies
in the Global Biotechnology industry.

( Industry Median: -10.90 vs. PTIX: -115.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
PTIX' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -115.4  Med: 0 Max: 0
Current: -115.4
-115.4
0

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 6.47
PTIX's Price-to-Net-Cash is ranked lower than
51% of the 739 Companies
in the Global Biotechnology industry.

( Industry Median: 6.36 vs. PTIX: 6.47 )
Ranked among companies with meaningful Price-to-Net-Cash only.
PTIX' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 0.14  Med: 14.71 Max: 503.7
Current: 6.47
0.14
503.7
Price-to-Net-Current-Asset-Value 6.29
PTIX's Price-to-Net-Current-Asset-Value is ranked lower than
55% of the 870 Companies
in the Global Biotechnology industry.

( Industry Median: 5.79 vs. PTIX: 6.29 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
PTIX' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.14  Med: 11.11 Max: 83.55
Current: 6.29
0.14
83.55
Price-to-Tangible-Book 6.29
PTIX's Price-to-Tangible-Book is ranked lower than
64% of the 1017 Companies
in the Global Biotechnology industry.

( Industry Median: 4.44 vs. PTIX: 6.29 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
PTIX' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.14  Med: 5.89 Max: 56.47
Current: 6.29
0.14
56.47
Earnings Yield (Greenblatt) % -12.59
PTIX's Earnings Yield (Greenblatt) % is ranked lower than
61% of the 1273 Companies
in the Global Biotechnology industry.

( Industry Median: -8.24 vs. PTIX: -12.59 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
PTIX' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -35.56  Med: 15.4 Max: 77179.5
Current: -12.59
-35.56
77179.5

More Statistics

EPS (TTM) $ -64.82
Beta-23.07
Short Percentage of Float16.44%
52-Week Range $1.06 - 175.00
Shares Outstanding (Mil)8.31

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)